Astrana Health, Inc.

Informe acción NasdaqCM:ASTH

Capitalización de mercado: US$2.1b

Astrana Health Dirección

Dirección controles de criterios 2/4

El CEO de Astrana Health es Brandon Sim , nombrado en Jan 2024, tiene una permanencia de menos de un año. compensación anual total es $14.31M, compuesta por 5% salario y 95% primas, incluidas acciones y opciones de la empresa. posee directamente un 3.33% de las acciones de la empresa, por valor de $68.85M. La antigüedad media del equipo directivo y de la junta directiva es de 1.3 años y 5.8 años, respectivamente.

Información clave

Brandon Sim

Chief Executive Officer (CEO)

US$14.3m

Compensación total

Porcentaje del salario del CEO5.0%
Permanencia del CEOless than a year
Participación del CEO3.3%
Permanencia media de la dirección1.3yrs
Promedio de permanencia en la Junta Directiva5.8yrs

Actualizaciones recientes de la dirección

Recent updates

Impressive Earnings May Not Tell The Whole Story For Astrana Health (NASDAQ:ASTH)

Nov 22
Impressive Earnings May Not Tell The Whole Story For Astrana Health (NASDAQ:ASTH)

Astrana Health, Inc.'s (NASDAQ:ASTH) 33% Cheaper Price Remains In Tune With Earnings

Nov 18
Astrana Health, Inc.'s (NASDAQ:ASTH) 33% Cheaper Price Remains In Tune With Earnings

Here's What Analysts Are Forecasting For Astrana Health, Inc. (NASDAQ:ASTH) After Its Third-Quarter Results

Nov 10
Here's What Analysts Are Forecasting For Astrana Health, Inc. (NASDAQ:ASTH) After Its Third-Quarter Results

Astrana Health, Inc.'s (NASDAQ:ASTH) P/E Is Still On The Mark Following 25% Share Price Bounce

Oct 04
Astrana Health, Inc.'s (NASDAQ:ASTH) P/E Is Still On The Mark Following 25% Share Price Bounce

Is Astrana Health, Inc. (NASDAQ:ASTH) Trading At A 21% Discount?

Sep 26
Is Astrana Health, Inc. (NASDAQ:ASTH) Trading At A 21% Discount?

Astrana Health's (NASDAQ:ASTH) Returns On Capital Not Reflecting Well On The Business

Sep 12
Astrana Health's (NASDAQ:ASTH) Returns On Capital Not Reflecting Well On The Business

Is Astrana Health (NASDAQ:ASTH) Using Too Much Debt?

Aug 28
Is Astrana Health (NASDAQ:ASTH) Using Too Much Debt?

Astrana Health, Inc.'s (NASDAQ:ASTH) 29% Jump Shows Its Popularity With Investors

Aug 02
Astrana Health, Inc.'s (NASDAQ:ASTH) 29% Jump Shows Its Popularity With Investors

Is There Now An Opportunity In Astrana Health, Inc. (NASDAQ:ASTH)?

Jun 19
Is There Now An Opportunity In Astrana Health, Inc. (NASDAQ:ASTH)?

Capital Allocation Trends At Astrana Health (NASDAQ:ASTH) Aren't Ideal

Jun 02
Capital Allocation Trends At Astrana Health (NASDAQ:ASTH) Aren't Ideal

Astrana Health, Inc. (NASDAQ:ASTH) First-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year

May 09
Astrana Health, Inc. (NASDAQ:ASTH) First-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year

Investors Still Waiting For A Pull Back In Astrana Health, Inc. (NASDAQ:ASTH)

Apr 15
Investors Still Waiting For A Pull Back In Astrana Health, Inc. (NASDAQ:ASTH)

At US$40.82, Is Apollo Medical Holdings, Inc. (NASDAQ:AMEH) Worth Looking At Closely?

Feb 25
At US$40.82, Is Apollo Medical Holdings, Inc. (NASDAQ:AMEH) Worth Looking At Closely?

Is Apollo Medical Holdings (NASDAQ:AMEH) Using Too Much Debt?

Feb 07
Is Apollo Medical Holdings (NASDAQ:AMEH) Using Too Much Debt?

Apollo Medical Holdings: Good Company, Not Quite A Hold

Jan 17

With Apollo Medical Holdings, Inc. (NASDAQ:AMEH) It Looks Like You'll Get What You Pay For

Dec 27
With Apollo Medical Holdings, Inc. (NASDAQ:AMEH) It Looks Like You'll Get What You Pay For

Returns On Capital At Apollo Medical Holdings (NASDAQ:AMEH) Have Stalled

Nov 08
Returns On Capital At Apollo Medical Holdings (NASDAQ:AMEH) Have Stalled

Should You Investigate Apollo Medical Holdings, Inc. (NASDAQ:AMEH) At US$30.62?

Oct 26
Should You Investigate Apollo Medical Holdings, Inc. (NASDAQ:AMEH) At US$30.62?

Apollo Medical Holdings (NASDAQ:AMEH) Has A Pretty Healthy Balance Sheet

Sep 22
Apollo Medical Holdings (NASDAQ:AMEH) Has A Pretty Healthy Balance Sheet

Returns At Apollo Medical Holdings (NASDAQ:AMEH) Appear To Be Weighed Down

Aug 04
Returns At Apollo Medical Holdings (NASDAQ:AMEH) Appear To Be Weighed Down

A Look At The Intrinsic Value Of Apollo Medical Holdings, Inc. (NASDAQ:AMEH)

Jul 19
A Look At The Intrinsic Value Of Apollo Medical Holdings, Inc. (NASDAQ:AMEH)

We Think Apollo Medical Holdings (NASDAQ:AMEH) Can Stay On Top Of Its Debt

Jun 19
We Think Apollo Medical Holdings (NASDAQ:AMEH) Can Stay On Top Of Its Debt

Apollo Medical Holdings' (NASDAQ:AMEH) Returns On Capital Are Heading Higher

May 05
Apollo Medical Holdings' (NASDAQ:AMEH) Returns On Capital Are Heading Higher

Does This Valuation Of Apollo Medical Holdings, Inc. (NASDAQ:AMEH) Imply Investors Are Overpaying?

Apr 20
Does This Valuation Of Apollo Medical Holdings, Inc. (NASDAQ:AMEH) Imply Investors Are Overpaying?

Is Apollo Medical Holdings (NASDAQ:AMEH) A Risky Investment?

Mar 21
Is Apollo Medical Holdings (NASDAQ:AMEH) A Risky Investment?

Apollo Medical Holdings (NASDAQ:AMEH) Has More To Do To Multiply In Value Going Forward

Jan 06
Apollo Medical Holdings (NASDAQ:AMEH) Has More To Do To Multiply In Value Going Forward

Is Apollo Medical Holdings (NASDAQ:AMEH) Using Too Much Debt?

Dec 16
Is Apollo Medical Holdings (NASDAQ:AMEH) Using Too Much Debt?

Análisis de compensación del CEO

¿Cómo ha cambiado la remuneración de Brandon Sim en comparación con los beneficios de Astrana Health?
FechaCompensación totalSalarioIngresos de la empresa
Sep 30 2024n/an/a

US$62m

Jun 30 2024n/an/a

US$68m

Mar 31 2024n/an/a

US$62m

Dec 31 2023US$14mUS$712k

US$61m

Sep 30 2023n/an/a

US$45m

Jun 30 2023n/an/a

US$46m

Mar 31 2023n/an/a

US$45m

Dec 31 2022US$15mUS$670k

US$45m

Sep 30 2022n/an/a

US$58m

Jun 30 2022n/an/a

US$69m

Mar 31 2022n/an/a

US$70m

Dec 31 2021US$9mUS$364k

US$69m

Sep 30 2021n/an/a

US$70m

Jun 30 2021n/an/a

US$53m

Mar 31 2021n/an/a

US$47m

Dec 31 2020US$1mUS$124k

US$38m

Sep 30 2020n/an/a

US$35m

Jun 30 2020n/an/a

US$22m

Mar 31 2020n/an/a

US$18m

Dec 31 2019US$73kUS$24k

US$14m

Compensación vs. Mercado: La compensación total de Brandon($USD14.31M) está por encima de la media de empresas de tamaño similar en el mercado US ($USD5.50M).

Compensación vs. Ingresos: La compensación de Brandon ha sido consistente con los resultados de la empresa en el último año.


CEO

Brandon Sim (30 yo)

less than a year

Permanencia

US$14,311,250

Compensación

Mr. Brandon K. Sim, MS, is President and Chief Executive Officer at Astrana Health, Inc. (formerly known as Apollo Medical Holdings, Inc.) since January 19, 2024 and had been its Co-Chief Executive Officer...


Equipo directivo

NombrePosiciónPermanenciaCompensaciónPropiedad
Kenneth Sim
Co-Founder & Executive Chairman6.9yrsUS$5.22m2.86%
$ 59.1m
Brandon Sim
President & CEOless than a yearUS$14.31m3.33%
$ 68.9m
Thomas Lam
Co-Founder & Vice Chairmanless than a yearUS$5.22m3.15%
$ 65.1m
Chandan Basho
CFO, COO & Corporate Secretary2.5yrsUS$5.70m0.34%
$ 7.0m
WaiChow Young
Senior Vice President of Health Affairsless than a yearUS$562.77k2.41%
$ 49.9m
John Vong
Chief Accounting Officer2.3yrssin datos0.036%
$ 743.4k
Rita Pew
Vice President of People & Operationsno datasin datossin datos
Jeremy Jackson
Chief Quality Officer3.7yrssin datossin datos
Neil Ahuja
President of Provider Solutions2.8yrssin datossin datos
Carlos Palacios
Chief Medical Officer for Texas1.3yrssin datossin datos
Dinesh Kumar
Chief Medical Officerless than a yearsin datos0.44%
$ 9.1m
Shawn Arnone
Managing Director of the Capital Markets Groupless than a yearsin datossin datos

1.3yrs

Permanencia media

55yo

Promedio de edad

Equipo directivo experimentado: El equipo directivo de ASTH no se considera experimentado ( 1.3 años antigüedad media), lo que sugiere un nuevo equipo.


Miembros de la Junta

NombrePosiciónPermanenciaCompensaciónPropiedad
Kenneth Sim
Co-Founder & Executive Chairman6.9yrsUS$5.22m2.86%
$ 59.1m
Thomas Lam
Co-Founder & Vice Chairmanless than a yearUS$5.22m3.15%
$ 65.1m
Weili Dai
Independent Director2.9yrsUS$211.95k0.015%
$ 303.9k
Mitchell Kitayama
Lead Independent Director6.9yrsUS$374.01k0.036%
$ 749.2k
David Schmidt
Independent Director11.5yrsUS$329.87k0.019%
$ 392.2k
John Chiang
Independent Director5.8yrsUS$273.71k0.034%
$ 702.4k
Matthew Mazdyasni
Director5.2yrsUS$274.13k0.017%
$ 350.2k
Linda Marsh
Director5.8yrsUS$211.95k0.16%
$ 3.3m
J. Estradas
Independent Director2.9yrssin datossin datos

5.8yrs

Permanencia media

70yo

Promedio de edad

Junta con experiencia: La junta directiva de ASTH se considera experimentada (5.8 años de antigüedad promedio).